IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 226 Development and validation of a new analytical RP-HPLC method for the determination of flavoxate hydrochloride in bulk form and pharmaceutical dosage form VarmaVegesna Kalyan MukeshChaganti KalyanNeenavath HoqueWalliqul Associate Professor, Department of Pharmaceutical Analysis, Sree Dattha Institute of Pharmacy Sheriguda(V), Ibrahimpatnam (M), Telangana, India Department of Pharmaceutical Analysis, Sree Dattha Institute of Pharmacy, Sagar Road, Sheriguda, Ibrahimpatnam, R.R, Telangana, India 2024 5 1 42 48 02012024 05022024 CC BY-NC-SA 4.0

A rapid and precise reverse phase high performance liquid chromatographic method has been developed for the validated of Flavoxate HCL, in its pure form as well as in tablet dosage form. Chromatography was carried out on a Symmetry C18 (4.6 x 150mm, 5µm) column using a mixture of Methanol and water (45:55% v/v) as the mobile phase at a flow rate of 0.8ml/min, the detection was carried out at 260nm. The retention time of the Flavoxate HCL was 2.379 ±0.02min respectively. The method produce linear responses in the concentration range of 24-120mg/ml of Flavoxate HCL. The method precision for the determination of assay was below 2.0%RSD. The method is useful in the quality control of bulk and pharmaceutical formulations. The method was validated for accuracy, precision, linearity, robustness, ruggedness and LOD & LOQ of standard solution. The developed RP-HPLC method was found to be accurate, precise, linear, and robust and was successful applied to a pharmaceutical tablet formulation for qualitative estimation of Flavoxate HCL in Bulk form and Marketed Pharmaceutical Dosage forms. 

 Flavoxate HCLRP-HPLCMethod DevelopmentValidationAccuracy References https://go.drugbank.com/drugs/DB01148 https://go.drugbank.com/salts/DBSALT000407 https://pubchem.ncbi.nlm.nih.gov/compound/Flavoxate -hydrochloride https://pubchem.ncbi.nlm.nih.gov/compound/Flavoxate https://en.wikipedia.org/wiki/Flavoxate Scholars Research Library. A review on: high performance liquid chromatography. Der Pharmacia Lettre. 2012;4(1):76–86. ISSN 0974-248X. FARMACIA. Farmacia. 2009;57(5). See also: Journal of Pharmacy and Bioallied Sciences. 2011;3(2):310–4. doi:10.4103/0975-7406.80766. Journal of Pharmaceutical and Biomedical Analysis. 1999;21(2):371–82. Tropical Journal of Pharmaceutical Research. 2009;8(5):449–54. Rabi Sankar. Instrumental Method of Analysis. p. P-18-6, P-18-3. Snyder LR, Kirkland JJ, Dolan JW. Practical HPLC Method Development. 2nd ed. New York: John Wiley & Sons; p. 503. U.S. Food and Drug Administration. Guidance for industry: analytical procedures and methods validation. U.S. Department of Health and Human Services, FDA; c2000. Available from: www.fda.gov/guidance/index.htm Cheng YF, Walter TH, Lu Z, Iraneta P, Gendreau C, Neue UD, Grassi JM, Carmody JL, O’Gara JE, Fisk RP. LCGC. 2000;18(10):1162. The United States Pharmacopeia 25/National Formulary International Journal of Medical and All Body Health Research www.allmedicaljournal.com 20. Ch. 1225. Rockville (MD): The United States Pharmacopeia Convention, Inc.; 2002. p. 2256-9. ICH Q2B: Validation of Analytical Procedure; Methodology. International Conference on Harmonization of Technical Requirements for the Registration of Drugs for Human Use, Geneva, Switzerland; May; c1997. ICH Q2B: Validation of Analytical Procedure; Methodology. International Conference on Harmonization of Technical Requirements for the Registration of Drugs for Human Use, Geneva, Switzerland; c2003. Gorenstein MV, Li JB, Van Antwerp J, Chapman D. LCGC. 1994;12(10):768-72. Young PM, Gorenstein MV. LCGC. 1994;12(11):832– 8. Warren WJ, Stanick WA, Gorenstein MV, Young PM. BioTechniques. 1995;2:282–97. Swartz ME. Journal of Liquid Chromatography. 2005;28(7–8):1253–63. Swartz M, Murphy B. American Laboratory. 2005;37(3):22–7. Swartz M. Pharmaceutical Formulation & Quality. 2004;6(5):40–2. Biomedical Chromatography: BMC. 2008 May;22(5):469–77. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2008;863(2):258– 65. Published 2008 Jan 18. Kassen müssen nicht für “Acomplia” zahlen. Tagesschau.de. 2006 Oct 17. Retrieved 2007 Jun 13. Matheson AJ, Noble S. Drugs. 2000 Apr;59(4):829–35. Peddi P, Rajeswari TR, Ganji RR. Development and validation of stability indicating RP-LC method for estimation of related substances of Flavoxate HCl in bulk and its pharmaceutical formulations. Der Pharmacia Lettre. 2016;8(9):286–94. Rashid AJ, Bashir S, Bukhari NI, Abbas N, Raza A, Munir A, Ijaz QA, Akbar S, Arshad N, Ishtiaq S. Development and validation of single analytical HPLC method for determination of Flavoxate HCl in bulk, tablets and biological fluids. Pakistan Journal of Pharmaceutical Sciences. 2021 Jul;34(4 Suppl):1629– 37. Attimarad M. Liquid chromatographic determination of Flavoxate HCl in pharmaceutical formulation. Journal of Young Pharmacists. 2010 Jul –Sep;2(3):280–3. doi:10.4103/0975-1483.66787. Attimarad M, Chohan MS, Balgoname AA. Simultaneous determination of Moxifloxacin and Flavoxate by RP-HPLC and ecofriendly derivative spectrophotometry methods in formulations. International Journal of Environmental Research and Public Health. 2019 Apr;16(7):1196. doi:10.3390/ijerph16071196. Copyright and License © 2026 The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.